Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 323, 191-202
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81872824, 81690261)
This publication has 36 references indexed in Scilit:
- Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic StrategiesArchivum Immunologiae et Therapiae Experimentalis, 2012
- Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: Synthesis, preparation and in vivo evaluationJournal of Controlled Release, 2012
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1Proceedings of the National Academy of Sciences, 2010
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2010
- Ferritins: A family of molecules for iron storage, antioxidation and moreBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Synthetic Low-Density Lipoprotein, a Novel Biomimetic Lipid Supplement for Serum-Free Tissue CultureBiotechnology Progress, 2008
- Immunogenicity of protein therapeuticsTrends in Immunology, 2007
- Active targeting of brain tumors using nanocarriersBiomaterials, 2007
- Paclitaxel–HSA interaction. Binding sites on HSA moleculeBioorganic & Medicinal Chemistry, 2004
- Solving the structure of human H ferritin by genetically engineering intermolecular crystal contactsNature, 1991